Suven Life Sciences Limited (BOM:530239)
India flag India · Delayed Price · Currency is INR
372.40
-2.05 (-0.55%)
At close: Aug 21, 2026

Suven Life Sciences Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-82.79150.26149.32370.1952.74
Short-Term Investments
-3,292227.011,4901,451-
Trading Asset Securities
-1,807222.79759.35463.39451.62
Cash & Short-Term Investments
5,1815,181600.052,3992,284504.36
Cash Growth
763.44%763.44%-74.98%5.01%352.91%8.80%
Accounts Receivable
-15.0813.3612.868.0712.98
Other Receivables
-56.5212.6622.0247.6775.25
Receivables
-71.6126.0234.8855.7488.23
Inventory
-53.132.387.080.080.33
Prepaid Expenses
-9.4110.025.93.574.33
Other Current Assets
-151.86116.26120.19172.1968.7
Total Current Assets
-5,467754.722,5672,516665.95
Property, Plant & Equipment
-764.47594.82280.1370.16408.91
Long-Term Investments
-8.750.49-1,000-
Other Intangible Assets
-1.451.811.991.982.25
Other Long-Term Assets
-0.39-0.211.13.25
Total Assets
-6,2421,3522,8493,8891,080

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-48.1352.2720.6816.6519.87
Accrued Expenses
-79.69182.59106.9182.4840.19
Current Portion of Long-Term Debt
-----4.84
Current Portion of Leases
-45.49-7.110.2611.51
Current Unearned Revenue
-----0.56
Other Current Liabilities
-14.21-0.471.916.18
Total Current Liabilities
-187.52234.86135.16111.383.15
Long-Term Leases
-121.45--5.7915.73
Pension & Post-Retirement Benefits
-0.63--3.777.97
Other Long-Term Liabilities
-18.5517.1113.4615.0512.05
Total Liabilities
-328.14251.97148.62135.91118.89

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-263.72218.07218.07218.07145.38
Additional Paid-In Capital
-12,4526,4686,4686,4682,566
Retained Earnings
--8,339-5,573-3,965-2,914-1,733
Comprehensive Income & Other
-1,537-12.91-20.42-18.99-17.46
Shareholders' Equity
5,9145,9141,1002,7003,753961.45
Total Liabilities & Equity
-6,2421,3522,8493,8891,080

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
166.94166.94-7.116.0532.09
Net Cash (Debt)
5,0145,014600.052,3922,268472.27
Net Cash Growth
735.62%735.62%-74.91%5.44%380.28%13.55%
Net Cash Per Share
20.9722.012.7510.9712.723.50
Filing Date Shares Outstanding
263.66263.72218.07218.07218.07145.38
Total Common Shares Outstanding
263.66263.72218.07218.07218.07145.38
Working Capital
-5,280519.862,4322,405582.8
Book Value Per Share
22.4322.435.0412.3817.216.61
Tangible Book Value
5,9135,9131,0982,6983,751959.21
Tangible Book Value Per Share
22.4222.425.0412.3717.206.60
Land
-329.29329.293.183.183.18
Machinery
-791.21794.82764.27860.18797.35
Construction In Progress
-35.960.1--35.51